PlexBio Co., Ltd. (6572.TWO)
Taipei Exchange · TWD · Healthcare · Medical Devices
NT$6.70 (+2.76%) as of
Key statistics
- Market cap
- 694.45M
- EPS (TTM)
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- 5.16 – 15.80
- Beta
- 1.09
- Revenue (TTM)
- 137.57M
- Profit margin
- -27.90%
- Volume
- 104.68k
About PlexBio Co., Ltd.
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It provides workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for pCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and customized pCode assays. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.